Globe Life (GL) Earnings Dates, Call Summary & Reports

Compare

634 Followers

Earnings Data

Report Date

May 06, 2026

After Close (Confirmed)

Period Ending

2026 (Q1)

Consensus EPS Forecast

3.49

Last Year’s EPS

3.07

Same Quarter Last Year

Analyst Consensus

Strong Buy

Based on 6 Analysts Ratings

Earnings Call Summary

Q4 2025

Earnings Call Date:Feb 04, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call highlights solid operational and financial momentum: year-over-year premium growth, improved life underwriting margins, agency sales strength (notably American Income, Family Heritage and United American), a successful DTC sales turnaround, raised 2026 guidance (net operating EPS and premium growth), active shareholder returns (large buybacks), and a strategic Bermuda reinsurance initiative to enhance future parent cash flow. Challenges include higher agent turnover at one major agency, elevated early lapses in internet-driven channels, a decline in excess investment income this quarter, interest-rate-driven unrealized bond losses ($1.2B), and some health-margin pressure and seasonality related to Medicare Supplement timing. Management provided detailed mitigation actions (retention initiatives, pricing/rate increases, conservative investment posture) and did not incorporate Bermuda dividend benefits into 2026 guidance. Overall the positives (growth, margins, guidance lift, capital returns and strategic initiatives) outweigh the identifiable operational and investment headwinds.

Company Guidance

Management guided 2026 net operating earnings per diluted share of $14.95–$15.65 (≈5% growth at the midpoint; normalized EPS growth ≈10%), with total premium revenue up ~7%–8% (life +4%–4.5%, health +14%–16%). Underwriting margins are expected to be 41.5%–44.5% for Life (with an anticipated Q3 assumption remeasurement gain of $50M–$100M lifting Q3 life margin to ~48%–52%) and 23%–27% for Health; administrative expenses are expected to be ~7.3% of premium. Investment guidance assumes ~$900M–$1.1B of fixed-maturity purchases at ~5.9%–6.0% and $300M–$400M of commercial mortgage loans/limited partnerships with 7%–9% expected cash returns, driving a blended earned yield of ~5.4%–5.5% (fixed-maturity yield ~5.3% for 2026); net investment income is expected to grow 3%–4%, required interest ≈4% and excess investment income relatively flat. Capital and liquidity guidance includes parent excess cash flow of ~$625M–$675M in 2026 (moving over time toward ~$200M annually from Bermuda reinsurance), planned shareholder distributions of $85M–$90M in dividends and $535M–$585M in share repurchases, year-end parent liquid assets of $50M–$60M, and a target consolidated RBC ratio of ~300%–320%.

Strong Quarterly and Full-Year Earnings

Q4 net income of $266M ($3.29/share) vs $255M ($3.01/share) a year ago; Q4 net operating income $274M ($3.39/share), up 8% vs prior-year operating EPS of $3.14. Full-year 2025 net operating income $14.52, $0.02 above prior midpoint guidance.

Premium Growth and Positive 2026 Guidance

Total premium revenue grew 5% in Q4 YoY. 2026 guidance expects total premium revenue growth of ~7%–8%, life premium growth 4%–4.5% and health premium growth 14%–16%.

Health and Life Underwriting Margin Improvements

Q4 life underwriting margin $350M, up 4% YoY. Q4 health underwriting margin $99M, up 9% YoY. Normalized full-year 2025 life underwriting margin improved to 41.0% of premium (from 39.7%).

Strong Distribution & Sales Momentum in Key Agencies

American Income: life premiums +6% to $457M, life underwriting margin +5% to $208M, net life sales +10% to $102M. Liberty National: life premiums +4%, net life sales +6%. Family Heritage: health premiums +10%, net health sales +15%, average producing agents +8%.

Direct-to-Consumer Sales Turnaround

Globe Life DTC life premiums ~flat at $244M while life underwriting margin rose 3% to $74M; net life sales +24% to $29M driven by new technology improving online conversion and lead-sharing with agencies.

United American Medicare Supplement Growth

United American health premiums +14% to $173M and net health sales $77M (up ~$47M YoY), driven by movement from Medicare Advantage to Medicare Supplement and approved premium rate increases.

Investment Portfolio and Yield Positioning

Invested assets $21.7B; fixed maturities $18.8B. Q4 fixed maturity yield 5.29% (up 2 bps YoY); recent fixed maturity purchases averaged ~6.23% yield. Management expects blended earned yield ~5.4%–5.5% for 2026 and plans $900M–$1.1B fixed maturity purchases plus $300M–$400M in commercial mortgage/partnerships.

Shareholder Returns and Parent Cash Flow

Repurchased 1.3M shares in Q4 for ~$170M; full-year 2025 repurchases 5.4M shares for $685M. Returned ~$770M to shareholders in 2025 (including ~$85M dividends). Parent excess cash flow ~ $620M in 2025 and forecast $625M–$675M in 2026; guidance anticipates $85M–$90M dividends and $535M–$585M buybacks in 2026.

Capital Positioning and Bermuda Reinsurance Initiative

Target consolidated RBC 300%–320%. Formed Globe Life Re Ltd. (Bermuda) and executed initial reinsurance (~$1.2B statutory reserves transferred); management expects Bermuda reinsurance to increase parent excess cash flow over time toward an incremental ~ $200M annually (not built into 2026).

Globe Life (GL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
May 06, 2026	2026 (Q1)	3.49 / -	3.07	―	―	―
Feb 04, 2026	2025 (Q4)	3.44 / 3.39	3.14	7.96% (+0.25)	―
Oct 22, 2025	2025 (Q3)	4.60 / 4.81	3.49	37.82% (+1.32)	―
Jul 23, 2025	2025 (Q2)	3.25 / 3.27	2.97	10.10% (+0.30)	―
Apr 30, 2025	2025 (Q1)	3.23 / 3.07	2.78	10.43% (+0.29)	―
Feb 05, 2025	2024 (Q4)	3.12 / 3.14	2.8	12.14% (+0.34)	―
Oct 23, 2024	2024 (Q3)	3.06 / 3.49	2.71	28.78% (+0.78)	―
Jul 24, 2024	2024 (Q2)	2.92 / 2.97	2.61	13.79% (+0.36)	―
Apr 22, 2024	2024 (Q1)	2.79 / 2.78	2.53	9.88% (+0.25)	―
Feb 07, 2024	2023 (Q4)	2.73 / 2.80	2.24	25.00% (+0.56)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Feb 04, 2026	$144.82	$146.95	+1.47%
Oct 22, 2025	$135.37	$135.44	+0.05%
Jul 23, 2025	$124.33	$131.01	+5.38%
Apr 30, 2025	$122.58	$117.00	-4.56%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Globe Life (GL) report earnings?

Globe Life (GL) is schdueled to report earning on May 06, 2026, After Close (Confirmed).

What is Globe Life (GL) earnings time?

Globe Life (GL) earnings time is at May 06, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is GL EPS forecast?

GL EPS forecast for the fiscal quarter 2026 (Q1) is 3.49.